Cargando…
Patient and retina specialists’ preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment
INTRODUCTION AND OBJECTIVE: Neovascular age-related macular degeneration (nAMD) leads to severe and permanent visual impairment, significantly impacting patients’ quality of life and functional independence. Although treatment with anti- vascular endothelial growth factor (VEGF) prevents and, in som...
Autores principales: | Gallego-Pinazo, Roberto, Pina-Marin, Begoña, Comellas, Marta, Aceituno, Susana, Gómez-Baldó, Laia, Blanch, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719669/ https://www.ncbi.nlm.nih.gov/pubmed/34972174 http://dx.doi.org/10.1371/journal.pone.0261955 |
Ejemplares similares
-
Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration
por: Zarranz-Ventura, Javier, et al.
Publicado: (2023) -
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
por: Schmidt-Erfurth, Ursula, et al.
Publicado: (2014) -
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021) -
Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2011) -
Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs
por: Casaroli-Marano, Ricardo, et al.
Publicado: (2014)